Results 141 to 150 of about 14,471,607 (152)
Some of the next articles are maybe not open access.

Des-gamma-carboxyprothrombin expression in cancer and/or non-cancer liver tissues: association with survival of patients with resectable hepatocellular carcinoma.

Oncology reports, 2005
Des-gamma-carboxyprothrombin (DCP), also known as a protein induced by vitamin K absence or antagonist II, is an abnormal prothrombin. The level of serum DCP is used in clinical diagnosis and prognosis of patients with hepatocellular carcinoma (HCC). Our previous immunohistochemical study showed that DCP is expressed not only in cancer tissues but also
Wei, Tang   +9 more
openaire   +1 more source

Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.

Hepato-gastroenterology, 1999
In the diagnosis of hepatocellular carcinoma (HCC), serum des-gamma-carboxyprothrombin (DCP) is a useful tumor marker. The conventional immunoassays for measurement of DCP levels, however, are not sensitive enough to detect small HCC. Therefore, we intended to elevate the minimal detection level of DCP by a modified enzyme linked immunosorbent assay ...
K, Soga   +5 more
openaire   +1 more source

Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis

Journal of Digestive Diseases, 2011
Yoshinori Inagaki   +2 more
exaly  

Des-Gamma-Carboxyprothrombin for Early Identification and Prognosis of Hepatocellular Carcinoma - A Case Control Study from Western Nepal

Asian Pacific Journal of Cancer Prevention, 2012
Jayadevan Sreedharan   +2 more
exaly  

Home - About - Disclaimer - Privacy